Quick Answer
PLUS THERAPEUTICS, INC. reported Total Revenue of $5.21 million for the year ending 2025.
- PLUS THERAPEUTICS, INC. showed a decrease of -10.5% in Total Revenue from 2024 to 2025.
- This data is from PLUS THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $2.09 million | Q3 2010: $1.52 million | Q1 2011: $1.36 million | Q2 2011: $2.41 million | Q3 2011: $2.13 million | Q4 2011: $2.08 million | Q1 2012: $1.48 million | Q2 2012: $1.95 million | Q3 2012: $1.31 million | Q4 2012: $3.97 million | Q1 2013: $1.39 million | Q2 2013: $1.41 million | Q3 2013: $1.62 million | Q4 2013: $2.71 million | Q1 2014: $1.03 million | Q2 2014: $935.0 thousand | Q3 2014: $518.0 thousand | Q4 2014: $2.47 million | Q1 2015: $902.0 thousand | Q2 2015: $1.61 million | Q3 2015: $766.0 thousand | Q4 2015: $1.56 million | Q1 2016: $1.33 million | Q2 2016: $1.13 million | Q3 2016: $731.0 thousand | Q4 2016: $1.47 million | Q1 2017: $591.0 thousand | Q2 2017: $969.0 thousand | Q3 2017: $467.0 thousand | Q3 2017: $467.0 thousand | Q4 2017: $662.0 thousand | Q1 2018: $731.0 thousand | Q1 2018: $731.0 thousand | Q2 2018: $660.0 thousand | Q3 2018: $858.0 thousand | Q1 2019: $703.0 thousand | Q1 2024: $1.68 million | Q2 2024: $1.28 million | Q3 2024: $1.46 million | Q1 2025: $1.06 million | Q2 2025: $1.39 million | Q3 2025: $1.40 million.
- Over the full 14 years of available data (2009 to 2025), PLUS THERAPEUTICS, INC.'s Total Revenue has declined by 10.7%.
- Historical annual values: Fiscal year 2025: $5.21 million | Fiscal year 2024: $5.82 million | Fiscal year 2023: $4.91 million | Fiscal year 2018: $3.67 million | Fiscal year 2017: $2.69 million | Fiscal year 2017: $2.69 million | Fiscal year 2016: $4.66 million | Fiscal year 2015: $4.84 million | Fiscal year 2014: $4.95 million | Fiscal year 2013: $7.12 million | Fiscal year 2012: $8.71 million | Fiscal year 2011: $7.98 million | Fiscal year 2010: $8.25 million | Fiscal year 2009: $5.84 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: